[1] |
|
[2] |
HUANG K W, YANG T, XU J Y,et al. Prevalence,risk factors,and management of asthma in China:a national cross-sectional study[J]. Lancet, 2019, 394(10196):407-418. DOI: 10.1016/S0140-6736(19)31147-X.
|
[3] |
|
[4] |
|
[5] |
LEE K H, LEE H S. Hypertension and diabetes mellitus as risk factors for asthma in Korean adults:the Sixth Korea National Health and Nutrition Examination Survey[J]. Int Health, 2020, 12(4):246-252. DOI: 10.1093/inthealth/ihz067.
|
[6] |
DOGRA S, ARDERN C I, BAKER J. The relationship between age of asthma onset and cardiovascular disease in Canadians[J]. J Asthma, 2007, 44(10):849-854. DOI: 10.1080/02770900701752391.
|
[7] |
FERGUSON S, TEODORESCU M C, GANGNON R E,et al. Factors associated with systemic hypertension in asthma[J]. Lung, 2014, 192(5):675-683. DOI: 10.1007/s00408-014-9600-y.
|
[8] |
CHRISTIANSEN S C, SCHATZ M, YANG S J,et al. Hypertension and asthma:a comorbid relationship[J]. J Allergy Clin Immunol Pract, 2016, 4(1):76-81. DOI: 10.1016/j.jaip.2015.07.009.
|
[9] |
SIN D D, WU L L, MAN S F P. The relationship between reduced lung function and cardiovascular mortality:a population-based study and a systematic review of the literature[J]. Chest, 2005, 127(6):1952-1959. DOI: 10.1378/chest.127.6.1952.
|
[10] |
BRAGINA E Y, GONCHAROVA I A, GARAEVA A F,et al. Molecular relationships between bronchial asthma and hypertension as comorbid diseases[J]. J Integr Bioinform, 2018, 15(4):20180052. DOI: 10.1515/jib-2018-0052.
|
[11] |
ZOLOTAREVA O, SAIK O V, KÖNIGS C,et al. Comorbidity of asthma and hypertension may be mediated by shared genetic dysregulation and drug side effects[J]. Sci Rep, 2019, 9(1):16302. DOI: 10.1038/s41598-019-52762-w.
|
[12] |
CHEN S Y, DENG Y, HE Q L,et al. Toll-like receptor 4 deficiency aggravates airway hyperresponsiveness and inflammation by impairing neutrophil apoptosis in a toluene diisocyanate-induced murine asthma model[J]. Allergy Asthma Immunol Res, 2020, 12(4):608-625. DOI: 10.4168/aair.2020.12.4.608.
|
[13] |
QI H M,CAO Q,LIU Q. TLR4 regulates vascular smooth muscle cell proliferation in hypertension via modulation of the NLRP3 inflammasome[J]. Am J Transl Res,2021,13(1):314-325.
|
[14] |
GODIN N, LIU F, LAU G J,et al. Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice[J]. Kidney Int, 2010, 77(12):1086-1097. DOI: 10.1038/ki.2010.63.
|
[15] |
MITSUNOBU F, YAMAOKA K, HANAMOTO K,et al. Elevation of antioxidant enzymes in the clinical effects of radon and thermal therapy for bronchial asthma[J]. J Radiat Res, 2003, 44(2):95-99. DOI: 10.1269/jrr.44.95.
|
[16] |
CHUNG F. Anti-inflammatory cytokines in asthma and allergy:interleukin-10,interleukin-12,interferon-gamma[J]. Mediators Inflamm, 2001, 10(2):51-59. DOI: 10.1080/09629350120054518.
|
[17] |
TINSLEY J H, SOUTH S, CHIASSON V L,et al. Interleukin-10 reduces inflammation,endothelial dysfunction,and blood pressure in hypertensive pregnant rats[J]. Am J Physiol Regul Integr Comp Physiol, 2010, 298(3):R713-719. DOI: 10.1152/ajpregu.00712.2009.
|
[18] |
HOTAMISLIGIL G S. Inflammation,metaflammation and immunometabolic disorders[J]. Nature, 2017, 542(7640):177-185. DOI: 10.1038/nature21363.
|
[19] |
RASMUSSEN F, MIKKELSEN D, HANCOX R J,et al. High-sensitive C-reactive protein is associated with reduced lung function in young adults[J]. Eur Respir J, 2009, 33(2):382-388. DOI: 10.1183/09031936.00040708.
|
[20] |
MOORE W C, HASTIE A T, LI X N,et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis[J]. J Allergy Clin Immunol, 2014, 133(6):1557-1563.e5. DOI: 10.1016/j.jaci.2013.10.011.
|
[21] |
RAUNDHAL M, MORSE C, KHARE A,et al. High IFN-γ and low SLPI mark severe asthma in mice and humans[J]. J Clin Invest, 2015, 125(8):3037-3050. DOI: 10.1172/JCI80911.
|
[22] |
CHRISTIANSEN S C, ZURAW B L. Treatment of hypertension in patients with asthma[J]. N Engl J Med, 2019, 381(11):1046-1057. DOI: 10.1056/NEJMra1800345.
|
[23] |
CHEN S C, AGRAWAL D K. Dysregulation of T cell subsets in the pathogenesis of hypertension[J]. Curr Hypertens Rep, 2015, 17(2):8. DOI: 10.1007/s11906-014-0521-1.
|
[24] |
KOCMALOVA M, ORAVEC M, ADAMKOV M,et al. Potassium ion channels and allergic asthma[J]. Adv Exp Med Biol, 2015, 838:35-45. DOI: 10.1007/5584_2014_76.
|
[25] |
OCHOA S V, OTERO L, ARISTIZABAL-PACHON A F,et al. Hypoxic regulation of the large-conductance,calcium and voltage-activated potassium channel,BK[J]. Front Physiol, 2021, 12:780206. DOI: 10.3389/fphys.2021.780206.
|
[26] |
LIU S F, ZHOU B, WANG Y F,et al. Pre-pregnancy maternal weight and gestational weight gain increase the risk for childhood asthma and wheeze:an updated meta-analysis[J]. Front Pediatr, 2020, 8:134. DOI: 10.3389/fped.2020.00134.
|
[27] |
|
[28] |
RASTOGI D, FRASER S, OH J,et al. Inflammation,metabolic dysregulation,and pulmonary function among obese urban adolescents with asthma[J]. Am J Respir Crit Care Med, 2015, 191(2):149-160. DOI: 10.1164/rccm.201409-1587OC.
|
[29] |
SERAVALLE G, GRASSI G. Sympathetic nervous system,hypertension,obesity and metabolic syndrome[J]. High Blood Press Cardiovasc Prev, 2016, 23(3):175-179. DOI: 10.1007/s40292-016-0137-4.
|
[30] |
MAO S Q, SUN J H, GU T L,et al. Hypomethylation of interleukin-6 (IL-6) gene increases the risk of essential hypertension:a matched case-control study[J]. J Hum Hypertens, 2017, 31(8):530-536. DOI: 10.1038/jhh.2017.7.
|
[31] |
HE F J, TAN M, MA Y,et al. Salt reduction to prevent hypertension and cardiovascular disease:JACC state-of-the-art review[J]. J Am Coll Cardiol, 2020, 75(6) :632-647. DOI: 10.1016/j.jacc.2019.11.055.
|
[32] |
BOONPIYATHAD T, SÖZENER Z C, SATITSUKSANOA P,et al. Immunologic mechanisms in asthma[J]. Semin Immunol, 2019, 46:101333. DOI: 10.1016/j.smim.2019.101333.
|
[33] |
JAVAID A, CUSHLEY M J, BONE M F. Effect of dietary salt on bronchial reactivity to histamine in asthma[J]. BMJ, 1988, 297(6646):454. DOI: 10.1136/bmj.297.6646.454.
|
[34] |
|
[35] |
MORALES D R, JACKSON C, LIPWORTH B J,et al. Adverse respiratory effect of acute β-blocker exposure in asthma:a systematic review and meta-analysis of randomized controlled trials[J]. Chest, 2014, 145(4):779-786. DOI: 10.1378/chest.13-1235.
|
[36] |
SALPETER S R, ORMISTON T M, SALPETER E E. Cardioselective beta-blockers in patients with reactive airway disease:a meta-analysis[J]. Ann Intern Med, 2002, 137(9):715-725. DOI: 10.7326/0003-4819-137-9-200211050-00035.
|
[37] |
MILLAR E A, ANGUS R M, HULKS G,et al. Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function[J]. Thorax, 1994, 49(5):492-495. DOI: 10.1136/thx.49.5.492.
|
[38] |
KIM M J, IM D S. Suppressive effects of type I angiotensin receptor antagonists,candesartan and irbesartan on allergic asthma[J]. Eur J Pharmacol, 2019, 852:25-33. DOI: 10.1016/j.ejphar.2019.02.035.
|
[39] |
TAN W S D, LIAO W P, ZHOU S,et al. Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases[J]. Curr Opin Pharmacol, 2018, 40:9-17. DOI: 10.1016/j.coph.2017.12.002.
|
[40] |
PATEL M, KURADE M, RAJALINGAM S,et al. Role of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in airway reactivity and inflammation in an allergic mouse model of asthma[J]. Immunopharmacol Immunotoxicol, 2019, 41(3):428-437. DOI: 10.1080/08923973.2019.1609026.
|
[41] |
OPPENHEIMER J, KELLY H W. Could calcium channel blockers treat 2 illnesses with 1 pill? [J]. Ann Allergy Asthma Immunol, 2017, 119(6):473-474. DOI: 10.1016/j.anai.2017.09.065.
|
[42] |
CHIU K Y, LI J G, LIN Y. Calcium channel blockers for lung function improvement in asthma:a systematic review and meta-analysis[J]. Ann Allergy Asthma Immunol, 2017, 119(6):518-523.e3. DOI: 10.1016/j.anai.2017.08.013.
|
[43] |
|
[44] |
GE W P, GUO X X, SONG X M,et al. The role of immunoglobulin E and mast cells in hypertension[J]. Cardiovasc Res, 2022:cvac010. DOI: 10.1093/cvr/cvac010.
|
[45] |
PELAIA C, CALABRESE C, TERRACCIANO R,et al. Omalizumab,the first available antibody for biological treatment of severe asthma:more than a decade of real-life effectiveness[J]. Ther Adv Respir Dis, 2018, 12:1753466618810192. DOI: 10.1177/1753466618810192.
|
[46] |
|
[47] |
NYENHUIS S M, DIXON A E, MA J. Impact of lifestyle interventions targeting healthy diet,physical activity,and weight loss on asthma in adults:what is the evidence?[J]. J Allergy Clin Immunol Pract, 2018, 6(3):751-763. DOI: 10.1016/j.jaip.2017.10.026.
|
[48] |
ANDRIANASOLO R M, KESSE-GUYOT E, ADJIBADE M,et al. Associations between dietary scores with asthma symptoms and asthma control in adults[J]. Eur Respir J, 2018, 52(1):1702572. DOI: 10.1183/13993003.02572-2017.
|